In the latest PDA Letter “On the Issue” video, PDA Chair Martin VanTrieste, recently retired from Amgen, discusses the issues currently impacting the pharmaceutical supply chain, including new serialization requirements from the EU and the continued threat from counterfeit pharmaceuticals. He draws from his years of experience to discuss what industry can do to respond to these supply chain challenges.